136 related articles for article (PubMed ID: 34941123)
1. Association between the prolonged use of magnesium sulfate for tocolysis and fracture risk among infants.
Wen YH; Wang IT; Lin FJ; Hsu HY; Wu CH
Medicine (Baltimore); 2021 Dec; 100(51):e28310. PubMed ID: 34941123
[TBL] [Abstract][Full Text] [Related]
2. Effect of magnesium sulfate and nifedipine on the risk of developing pulmonary edema in preterm births.
Xiao C; Gangal M; Abenhaim HA
J Perinat Med; 2014 Sep; 42(5):585-9. PubMed ID: 24566358
[TBL] [Abstract][Full Text] [Related]
3. Antenatal magnesium sulfate for both tocolysis and fetal neuroprotection in premature rupture of the membranes before 32 weeks' gestation.
Jung EJ; Byun JM; Kim YN; Lee KB; Sung MS; Kim KT; Shin JB; Jeong DH
J Matern Fetal Neonatal Med; 2018 Jun; 31(11):1431-1441. PubMed ID: 28391733
[TBL] [Abstract][Full Text] [Related]
4. Can magnesium sulfate reduce the risk of cerebral palsy in very low birthweight infants?
Nelson KB; Grether JK
Pediatrics; 1995 Feb; 95(2):263-9. PubMed ID: 7838646
[TBL] [Abstract][Full Text] [Related]
5. Long-term magnesium sulfate tocolysis and maternal osteoporosis in a triplet pregnancy: a case report.
Levav AL; Chan L; Wapner RJ
Am J Perinatol; 1998 Jan; 15(1):43-6. PubMed ID: 9475687
[TBL] [Abstract][Full Text] [Related]
6. Magnesium sulfate tocolysis and intraventricular hemorrhage in very preterm infants.
Petrova A; Mehta R
Indian J Pediatr; 2012 Jan; 79(1):43-7. PubMed ID: 21625843
[TBL] [Abstract][Full Text] [Related]
7. Magnesium sulfate tocolysis and pulmonary edema: the drug or the vehicle?
Samol JM; Lambers DS
Am J Obstet Gynecol; 2005 May; 192(5):1430-2. PubMed ID: 15902128
[TBL] [Abstract][Full Text] [Related]
8. Short- and long-term outcomes in babies born after antenatal magnesium treatment.
Mitani M; Matsuda Y; Shimada E;
J Obstet Gynaecol Res; 2011 Nov; 37(11):1609-14. PubMed ID: 21733038
[TBL] [Abstract][Full Text] [Related]
9. Effect of magnesium sulfate treatment on neonatal bone abnormalities.
Matsuda Y; Maeda Y; Ito M; Sakamoto H; Masaoka N; Takada M; Sato K
Gynecol Obstet Invest; 1997; 44(2):82-8. PubMed ID: 9286718
[TBL] [Abstract][Full Text] [Related]
10. Magnesium sulfate tocolysis and risk of neonatal death.
Grether JK; Hoogstrate J; Selvin S; Nelson KB
Am J Obstet Gynecol; 1998 Jan; 178(1 Pt 1):1-6. PubMed ID: 9465794
[TBL] [Abstract][Full Text] [Related]
11. Factors affecting maternal serum magnesium levels during long-term magnesium sulfate tocolysis in singleton and twin pregnancy.
Nakazawa H; Uchida A; Minamitani T; Makishi A; Takamatsu Y; Kiyoshi K; Samoto T; Funakoshi T
J Obstet Gynaecol Res; 2015 Aug; 41(8):1178-84. PubMed ID: 25857633
[TBL] [Abstract][Full Text] [Related]
12. Impact of tocolysis-intent magnesium sulfate and beta-adrenergic agonists on perinatal brain damage in infants born between 28-36 weeks' gestation.
Kino E; Ohhashi M; Kawagoe Y; Sameshima H; Kamitomo M; Suga S; Yasuhi I; Funakoshi T
J Obstet Gynaecol Res; 2020 Oct; 46(10):2027-2035. PubMed ID: 32779268
[TBL] [Abstract][Full Text] [Related]
13. Magnesium sulfate tocolysis: time to quit.
Grimes DA; Nanda K
Obstet Gynecol; 2006 Oct; 108(4):986-9. PubMed ID: 17012463
[TBL] [Abstract][Full Text] [Related]
14. Magnesium sulfate.
Gordon MC; Iams JD
Clin Obstet Gynecol; 1995 Dec; 38(4):706-12. PubMed ID: 8616968
[TBL] [Abstract][Full Text] [Related]
15. Tocolysis in women with preterm labor between 32 0/7 and 34 6/7 weeks of gestation: a randomized controlled pilot study.
How HY; Zafaranchi L; Stella CL; Recht K; Maxwell RA; Sibai BM; Spinnato JA
Am J Obstet Gynecol; 2006 Apr; 194(4):976-81. PubMed ID: 16580286
[TBL] [Abstract][Full Text] [Related]
16. The effects of maternal magnesium sulfate treatment on newborns: a prospective controlled study.
Riaz M; Porat R; Brodsky NL; Hurt H
J Perinatol; 1998; 18(6 Pt 1):449-54. PubMed ID: 9848759
[TBL] [Abstract][Full Text] [Related]
17. Tocolysis and the risk of nonreassuring fetal status among pregnant women in labor: Findings from a population-based retrospective cohort study.
Wang IT; Tsai MT; Erickson SR; Wu CH
Medicine (Baltimore); 2019 Dec; 98(50):e18190. PubMed ID: 31852074
[TBL] [Abstract][Full Text] [Related]
18. Adverse maternal and neonatal outcome of prolonged course of magnesium sulfate tocolysis.
Nassar AH; Sakhel K; Maarouf H; Naassan GR; Usta IM
Acta Obstet Gynecol Scand; 2006; 85(9):1099-103. PubMed ID: 16929415
[TBL] [Abstract][Full Text] [Related]
19. Maternal osteoporosis after prolonged magnesium sulfate tocolysis therapy: a case report.
Hung JW; Tsai MY; Yang BY; Chen JF
Arch Phys Med Rehabil; 2005 Jan; 86(1):146-9. PubMed ID: 15641005
[TBL] [Abstract][Full Text] [Related]
20. Effect of maternal tocolysis on the incidence of severe periventricular/intraventricular haemorrhage in very low birthweight infants.
Weintraub Z; Solovechick M; Reichman B; Rotschild A; Waisman D; Davkin O; Lusky A; Bental Y;
Arch Dis Child Fetal Neonatal Ed; 2001 Jul; 85(1):F13-7. PubMed ID: 11420315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
